Evidence map›Paper›PMID 38342586›Full record

ArticleAdvanced biology2024

The Association Between C24:0/C16:0 Ceramide Ratio and Cardiorespiratory Fitness is Robust to Effect Modifications by Age and Sex.

Jule Zatloukal, Stephanie Zylla, Marcello R P Markus, Ralf Ewert, Sven Gläser, Henry Völzke, Diana Albrecht, Nele Friedrich, Matthias Nauck, Linda R Peterson and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Advanced biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. The Role of Ceramides in Metabolic and Cardiovascular Diseases.Journal of cardiovascular development and disease · 2026
    Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Jule ZatloukalDept. of Internal Medicine B, University Medicine Greifswald, 17475, Greifswald, Germany.
Stephanie ZyllaGerman Centre for Cardiovascular Research (DZHK), 17475, Partner-site Greifswald, Germany.
Marcello R P MarkusDept. of Internal Medicine B, University Medicine Greifswald, 17475, Greifswald, Germany.
Ralf EwertDept. of Internal Medicine B, University Medicine Greifswald, 17475, Greifswald, Germany.
Sven GläserDept. of Internal Medicine B, University Medicine Greifswald, 17475, Greifswald, Germany.
Henry VölzkeGerman Centre for Cardiovascular Research (DZHK), 17475, Partner-site Greifswald, Germany.
Diana AlbrechtInstitute of Community Medicine, University Medicine Greifswald, 17475, Greifswald, Germany.
Nele FriedrichGerman Centre for Cardiovascular Research (DZHK), 17475, Partner-site Greifswald, Germany.
Matthias NauckGerman Centre for Cardiovascular Research (DZHK), 17475, Partner-site Greifswald, Germany.
Linda R PetersonDivision of Cardiology, Department of Medicine, Washington University, St Louis, MO, 63110, USA.
Xuntian JiangDivision of Cardiology, Department of Medicine, Washington University, St Louis, MO, 63110, USA.
Jean E SchafferJoslin Diabetes Center, Harvard Medical School, Boston, MA, 02215, USA.
Stephan B FelixDept. of Internal Medicine B, University Medicine Greifswald, 17475, Greifswald, Germany.
Marcus DörrDept. of Internal Medicine B, University Medicine Greifswald, 17475, Greifswald, Germany.
Martin BahlsDept. of Internal Medicine B, University Medicine Greifswald, 17475, Greifswald, Germany.
Stefan GrossDept. of Internal Medicine B, University Medicine Greifswald, 17475, Greifswald, Germany.ORCID 0000-0003-4121-7161
Universitätsmedizin Greifswald · DEWashington University in St. Louis · USJoslin Diabetes Center · US

Funding

WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Clay F. Semenkovich · 2013 to 2026
$27.1M
Lipid Biomarkers for Diabetic Heart DiseaseP20HL113444 · NHLBI · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 2012 to 2016
$4.7M
The Inorganic Nitrate and eXercise performance in Heart Failure (iNIX-HF): - a phase II clinical trialR33HL155858 · NHLBI · WASHINGTON UNIVERSITY · PI ANDREW R COGGAN, LINDA Ruth PETERSON · 2023 to 2026
$2.9M
NHLBI NIH HHS P20 HL113444NHLBI NIH HHS R33 HL155858NIDDK NIH HHS P30 DK020579NIH HHS P20 HL113444NIH HHS P30 DK020579
6 · The paper itself

Abstract

Ceramides and cardiorespiratory (CR) fitness are both related to cardiovascular diseases. The associations of three blood plasma ceramides (C16:0, C22:0, and C24:0) with CR fitness in the population-based Study of Health in Pomerania (SHIP-START-1; n = 1,102; mean age 50.3 years, 51.5% women) are investigated. In addition, subgroup analysis according to age (</≥54 years) and sex (female/male) is performed. Ceramides are quantified by liquid chromatography/mass spectrometry (LC/MS). CR fitness is assessed by a cardiopulmonary exercise test. Sex and age independent associations are found for higher levels of C24:0 and C24:0/C16:0 ratio with higher maximal oxygen consumption (VO

Indexed as

Cardiorespiratory FitnessCardiovascular DiseasesBiomarkersCeramidesFemaleHumansMaleMiddle AgedBiomarkersCeramidescardiopulmonary exercise testcardiorespiratory fitnesscardiovascular risk factorsceramides

Identifiers

PMID38342586
PMCPMC11149399
OpenAlexW4392730232

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.